Current status of wearable cardioverter-defibrillator use in Japan

被引:0
|
作者
Tonegawa-Kuji, Reina [1 ]
Nishida, Taku [2 ]
Sumita, Yoko [1 ]
Miyamoto, Yoshihiro [3 ]
Kanaoka, Koshiro [1 ,2 ]
机构
[1] Natl Cerebral & Cardiovasc Ctr, Dept Med & Hlth Informat Management, 6-1 Kishibe Shimmachi, Suita, Osaka 5648565, Japan
[2] Nara Med Univ, Dept Cardiovasc Med, Nara, Japan
[3] Natl Cerebral & Cardiovasc Ctr, Open Innovat Ctr, Suita, Japan
基金
日本学术振兴会;
关键词
arrhythmia; cardiopulmonary arrest; implantable cardioverter-defibrillator; sudden cardiac death;
D O I
10.1002/joa3.13113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe current status of wearable cardiovascular defibrillators (WCD) use in Japan is unclear.MethodsUsing a nationwide claims database of Japan, we assessed characteristics of patients using WCD and factors influencing subsequent implantable cardioverter-defibrillator (ICD) implantation.ResultsIn 1049 cases, those with prior cardiopulmonary arrest (CPA) or ventricular arrhythmia, cardiomyopathy, or device-related issues were more likely to require permanent ICDs, whereas females were less likely.ConclusionsPrior CPA or fatal arrhythmia, underlying cardiomyopathy, or device-related issues were associated with future permanent ICD implantation. These findings offer insights into the current status of WCD use in Japan. Using a nationwide claims database of Japan, we assessed characteristics of patients using wearable cardiovascular defibrillators and factors influencing subsequent implantable cardioverter-defibrillator (ICD) implantation. In 1049 cases, those with prior cardiopulmonary arrest or ventricular arrhythmia, cardiomyopathy, or device-related issues were more likely to require permanent ICDs, whereas females were less likely.image
引用
收藏
页码:998 / 1000
页数:3
相关论文
共 50 条
  • [31] Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation
    Healy, Christopher A.
    Carrillo, Roger G.
    HEART RHYTHM, 2015, 12 (07) : 1565 - 1573
  • [32] Use of wearable cardioverter-defibrillator in association with catheter ablation for atrial fibrillation-related tachycardiomyopathy
    Conti, Sergio
    Bonomo, Vito
    Taormina, Antonio
    Giordano, Umberto
    Sgarito, Giuseppe
    CLINICAL CASE REPORTS, 2019, 7 (05): : 995 - 998
  • [33] Implantable cardioverter-defibrillator prescription in the elderly
    Epstein, Andrew E.
    Kay, G. Neal
    Plumb, Vance J.
    McElderry, H. Thomas
    Doppalapudi, Harish
    Yamada, Takumi
    Shafiroff, Jeff
    Syed, Zaffer A.
    Shkurovich, Sergio
    HEART RHYTHM, 2009, 6 (08) : 1136 - 1143
  • [34] Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
    El-Battrawy, Ibrahim
    Kovacs, Boldizsar
    Dreher, Tobias C.
    Klein, Norbert
    Rosenkaimer, Stephanie
    Roger, Susanne
    Kuschyk, Jurgen
    Saguner, Ardan Muammer
    Kowitz, Jacqueline
    Erath, Julia W.
    Duru, Firat
    Akin, Ibrahim
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [35] Sudden cardiac death while waiting: do we need the wearable cardioverter-defibrillator?
    Carsten Israel
    Ingo Staudacher
    Christophe Leclercq
    Giovanni Luca Botto
    Daniel Scherr
    Andreas Fach
    Firat Duru
    Maura M. Zylla
    Hugo A. Katus
    Dierk Thomas
    Clinical Research in Cardiology, 2022, 111 : 1189 - 1197
  • [36] Sudden cardiac death while waiting: do we need the wearable cardioverter-defibrillator?
    Israel, Carsten
    Staudacher, Ingo
    Leclercq, Christophe
    Botto, Giovanni Luca
    Scherr, Daniel
    Fach, Andreas
    Duru, Firat
    Zylla, Maura M.
    Katus, Hugo A.
    Thomas, Dierk
    CLINICAL RESEARCH IN CARDIOLOGY, 2022, 111 (11) : 1189 - 1197
  • [37] The wearable cardioverter-defibrillator is not needed for most high-risk patients
    Bhatt, Advay G.
    Mittal, Suneet
    HEART RHYTHM O2, 2020, 1 (03): : 230 - 233
  • [38] Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication
    Schaer, Beat
    Kuehne, Michael
    Reichlin, Tobias
    Osswald, Stefan
    Sticherling, Christian
    EUROPACE, 2016, 18 (02): : 227 - 231
  • [39] The current status of the implantable cardioverter defibrillator
    Gillis, AM
    ANNUAL REVIEW OF MEDICINE, 1996, 47 : 85 - 93
  • [40] Time to Shock the System: Moving Beyond the Current Paradigm for Primary Prevention Implantable Cardioverter-Defibrillator Use
    Merchant, Faisal M.
    Levy, Wayne C.
    Kramer, Daniel B.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (05):